NAT10 and neoplasm: Furthermore, G‐749 is screened and identified as a novel NAT10 inhibitor capable of effectively impeding lysosomal acidification and tumor metastasis by disrupting the NAT10‐Ubiquitin‐specific Peptidase 39 (USP39) interaction.